Sun Product Research Heats Up; U.K. Agency Warns About Unapproved OTC
This article was originally published in The Tan Sheet
Executive Summary
As pharmaceutical firms work on injectable products that in the future could compete with sunscreens and suntan oils and lotions, health authorities in the U.K. warn that an unapproved drug marketed as "injectable tan" is being sold over the counter there
You may also be interested in...
Regulatory News In Brief: Dakota Lab shutters, FDA warns on web links and supplement GMPs, melanotan caution in U.K.
Dakota Labs shutters under decree; Herbal Papaya web links render products drugs; FDA flags firms for GMPs; U.K. watchdog cites ketone marketer; MHRA cautions against melanotan use; and Aidapak recalls products from hospitals.
Regulatory News In Brief: Dakota Lab shutters, FDA warns on web links and supplement GMPs, melanotan caution in U.K.
Dakota Labs shutters under decree; Herbal Papaya web links render products drugs; FDA flags firms for GMPs; U.K. watchdog cites ketone marketer; MHRA cautions against melanotan use; and Aidapak recalls products from hospitals.
Injectable tan crackdown
The U.K.'s Medicines and Healthcare products Regulatory Agency advises Nov. 17 against using the unlicensed drug Melanotan, an injectable tan sold illegally as a nonprescription product on Web sites and in some gyms and tanning salons. Melanotan increases the body's melanin levels to create a tan, but the substance "has not been tested for safety, quality or effectiveness" in the U.K., MHRA says